Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 15Plasma cell 5Sarcoma 2Other hematologic neoplasm 2Dermatologic 2Breast 2Thoracic 1Myeloid 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Melanoma 33Carcinoma, Non-Small-Cell Lung 6Uveal Melanoma 5Skin Neoplasms 5Neoplasms 5Lymphoma, T-Cell, Cutaneous 4Kidney Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Mycosis Fungoides 3Esophageal Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Sezary Syndrome 2Ovarian Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Endometrial Neoplasms 2Carcinoma, Basal Cell 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urticaria Pigmentosa 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Small Cell Lung Carcinoma 1Pruritus 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 32fludarabine phosphate 25Peripheral Blood Stem Cell Transplantation 25Busulfan 20Antilymphocyte Serum 19Tacrolimus 15Mycophenolic Acid 15Filgrastim 15Cyclosporine 15Methotrexate 14Melphalan 12Etoposide 12pembrolizumab 11Whole-Body Irradiation 10Radiotherapy 10Methylprednisolone 10Sirolimus 9Psychiatric Rehabilitation 8Nivolumab 8Bortezomib 8fludarabine 7Prednisone 7Flow Cytometry 7sargramostim 6romidepsin 6Vorinostat 6Gemcitabine 6Doxorubicin 6Cord Blood Stem Cell Transplantation 6aldesleukin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma × Blood Specimen Collection × Dermatologic × Clear all
NCT06382844 2025-05-01

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

Instituto de Investigación Biomédica de Salamanca

Recruiting
100 enrolled
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
11 enrolled
DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡